Pharmaceutical Preparations — Ranked by Revenue
SIC 2834 · Annual figures from SEC 10-K filings
These rankings show the largest Pharmaceutical Preparations companies by revenue, based on the most recent fiscal year data reported in their annual 10-K filings with the SEC. Only companies with XBRL-tagged financial data are included. Use the tabs below to switch between revenue, net income, and total assets.
| # | Company | Revenue | Fiscal Year |
|---|---|---|---|
| 1 | JOHNSON & JOHNSON JNJ | $94.19B | FY2025 |
| 2 | ELI LILLY & Co LLY | $65.18B | FY2025 |
| 3 | Merck & Co., Inc. MRK | $65.01B | FY2025 |
| 4 | PFIZER INC PFE | $51.58B | FY2013 |
| 5 | TEVA PHARMACEUTICAL INDUSTRIES LTD TEVJF | $17.26B | FY2025 |
| 6 | REGENERON PHARMACEUTICALS, INC. REGN | $14.34B | FY2025 |
| 7 | Viatris Inc VTRS | $14.25B | FY2025 |
| 8 | VERTEX PHARMACEUTICALS INC / MA VRTX | $12.00B | FY2025 |
| 9 | Bausch Health Companies Inc. BHC | $10.27B | FY2025 |
| 10 | AbbVie Inc. ABBV | $7.74B | FY2017 |
| 11 | ABBOTT LABORATORIES ABT | $7.59B | FY2017 |
| 12 | Organon & Co. OGN | $6.22B | FY2025 |
| 13 | BRISTOL MYERS SQUIBB CO CELG-RI | $5.45B | FY2017 |
| 14 | BeOne Medicines Ltd. BEIGF | $5.34B | FY2025 |
| 15 | Elanco Animal Health Inc ELAN | $4.72B | FY2025 |
| 16 | Jazz Pharmaceuticals plc JAZZ | $4.27B | FY2025 |
| 17 | BIOMARIN PHARMACEUTICAL INC BMRN | $3.22B | FY2025 |
| 18 | UNITED THERAPEUTICS Corp UTHR | $3.18B | FY2025 |
| 19 | Amneal Pharmaceuticals, Inc. AMRX | $3.02B | FY2025 |
| 20 | Royalty Pharma plc RPRX | $2.38B | FY2025 |
| 21 | Sarepta Therapeutics, Inc. SRPT | $1.86B | FY2025 |
| 22 | Zoetis Inc. ZTS | $1.46B | FY2017 |
| 23 | PERRIGO Co plc PRGO | $1.33B | FY2016 |
| 24 | PHIBRO ANIMAL HEALTH CORP PAHC | $1.30B | FY2025 |
| 25 | Indivior Pharmaceuticals, Inc. INDV | $1.24B | FY2025 |
| 26 | ACADIA PHARMACEUTICALS INC ACAD | $1.07B | FY2025 |
| 27 | Apellis Pharmaceuticals, Inc. APLS | $1.00B | FY2025 |
| 28 | MADRIGAL PHARMACEUTICALS, INC. MDGL | $958.40M | FY2025 |
| 29 | IONIS PHARMACEUTICALS INC IONS | $943.71M | FY2025 |
| 30 | Alkermes plc. ALKS | $903.37M | FY2017 |
| 31 | ANI PHARMACEUTICALS INC ANIP | $883.37M | FY2025 |
| 32 | Harmony Biosciences Holdings, Inc. HRMY | $868.45M | FY2025 |
| 33 | ARROWHEAD PHARMACEUTICALS, INC. ARWR | $829.45M | FY2025 |
| 34 | Pacira BioSciences, Inc. PCRX | $726.41M | FY2025 |
| 35 | Kiniksa Pharmaceuticals International, plc KNSA | $677.56M | FY2025 |
| 36 | Axsome Therapeutics, Inc. AXSM | $638.50M | FY2025 |
| 37 | TG THERAPEUTICS, INC. TGTX | $616.29M | FY2025 |
| 38 | INSMED Inc INSM | $606.42M | FY2025 |
| 39 | CATALYST PHARMACEUTICALS, INC. CPRX | $588.99M | FY2025 |
| 40 | LIFECORE BIOMEDICAL, INC. \DE\ LFCR | $532.26M | FY2017 |
| 41 | Mirum Pharmaceuticals, Inc. MIRM | $521.31M | FY2025 |
| 42 | BridgeBio Pharma, Inc. BBIO | $502.08M | FY2025 |
| 43 | Travere Therapeutics, Inc. TVTX | $490.73M | FY2025 |
| 44 | Zai Lab Ltd ZLAB | $457.18M | FY2025 |
| 45 | Innoviva, Inc. INVA | $411.33M | FY2025 |
| 46 | ARDELYX, INC. ARDX | $407.32M | FY2025 |
| 47 | Esperion Therapeutics, Inc. ESPR | $403.14M | FY2025 |
| 48 | Arcutis Biotherapeutics, Inc. ARQT | $376.07M | FY2025 |
| 49 | Atea Pharmaceuticals, Inc. AVIR | $351.37M | FY2022 |
| 50 | CorMedix Inc. CRMD | $311.71M | FY2025 |